Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC518715784;15785;15786 chr2:178733830;178733829;178733828chr2:179598557;179598556;179598555
N2AB487014833;14834;14835 chr2:178733830;178733829;178733828chr2:179598557;179598556;179598555
N2A394312052;12053;12054 chr2:178733830;178733829;178733828chr2:179598557;179598556;179598555
N2BNoneNone chr2:Nonechr2:None
Novex-1NoneNone chr2:Nonechr2:None
Novex-2NoneNone chr2:Nonechr2:None
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: L
  • RefSeq wild type transcript codon: CTG
  • RefSeq wild type template codon: GAC
  • Domain: Ig-35
  • Domain position: 20
  • Structural Position: 30
  • Q(SASA): 0.1778
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
L/P None None 0.999 D 0.897 0.854 0.90282609855 gnomAD-4.0.0 6.84277E-07 None None None None N None 0 0 None 0 0 None 0 0 8.9956E-07 0 0
L/Q None None 0.997 D 0.888 0.79 0.895693387583 gnomAD-4.0.0 6.84277E-07 None None None None N None 0 0 None 0 2.51978E-05 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
L/A 0.8357 likely_pathogenic 0.8937 pathogenic -2.503 Highly Destabilizing 0.983 D 0.729 prob.delet. None None None None N
L/C 0.8177 likely_pathogenic 0.8777 pathogenic -1.767 Destabilizing 1.0 D 0.804 deleterious None None None None N
L/D 0.9967 likely_pathogenic 0.9983 pathogenic -3.123 Highly Destabilizing 0.999 D 0.899 deleterious None None None None N
L/E 0.9758 likely_pathogenic 0.9861 pathogenic -2.822 Highly Destabilizing 0.998 D 0.89 deleterious None None None None N
L/F 0.0972 likely_benign 0.1193 benign -1.469 Destabilizing 0.995 D 0.787 deleterious None None None None N
L/G 0.9642 likely_pathogenic 0.9795 pathogenic -3.084 Highly Destabilizing 0.998 D 0.888 deleterious None None None None N
L/H 0.8608 likely_pathogenic 0.915 pathogenic -2.598 Highly Destabilizing 1.0 D 0.865 deleterious None None None None N
L/I 0.1269 likely_benign 0.1436 benign -0.777 Destabilizing 0.966 D 0.608 neutral None None None None N
L/K 0.9434 likely_pathogenic 0.9673 pathogenic -2.016 Highly Destabilizing 0.998 D 0.883 deleterious None None None None N
L/M 0.1409 likely_benign 0.1605 benign -0.836 Destabilizing 0.898 D 0.547 neutral D 0.57361859 None None N
L/N 0.9781 likely_pathogenic 0.9881 pathogenic -2.622 Highly Destabilizing 0.999 D 0.9 deleterious None None None None N
L/P 0.9882 likely_pathogenic 0.9917 pathogenic -1.34 Destabilizing 0.999 D 0.897 deleterious D 0.843746367 None None N
L/Q 0.8464 likely_pathogenic 0.9017 pathogenic -2.332 Highly Destabilizing 0.997 D 0.888 deleterious D 0.843746367 None None N
L/R 0.8901 likely_pathogenic 0.9315 pathogenic -2.019 Highly Destabilizing 0.997 D 0.881 deleterious D 0.843746367 None None N
L/S 0.9365 likely_pathogenic 0.9643 pathogenic -3.235 Highly Destabilizing 0.998 D 0.88 deleterious None None None None N
L/T 0.8951 likely_pathogenic 0.937 pathogenic -2.768 Highly Destabilizing 0.995 D 0.806 deleterious None None None None N
L/V 0.17 likely_benign 0.2038 benign -1.34 Destabilizing 0.955 D 0.636 neutral D 0.704838234 None None N
L/W 0.5119 ambiguous 0.6072 pathogenic -1.822 Destabilizing 1.0 D 0.82 deleterious None None None None N
L/Y 0.6236 likely_pathogenic 0.7189 pathogenic -1.549 Destabilizing 0.998 D 0.823 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.